No Data
No Data
AC Immune Showcasing Its Novel Morphomer-Antibody Drug Conjugate (MorADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024
PDF VersionAC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024Three oral presentations at the Alzheimer's
AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)
AC Immune SA (NASDAQ:ACIU) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
AC Immune SA (NASDAQ:ACIU) shareholders would be excited to see that the share price has had a great month, posting a 34% gain and recovering from prior weakness. The annual gain comes to 113% foll
Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet
RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around 250 points on Friday.Shares of RH (NYSE:RH) fell sharply in today's pre-market trading after the company reported mixed
BTIG Maintains AC Immune(ACIU.US) With Buy Rating, Maintains Target Price $8
BTIG analyst Thomas Shrader maintains $AC Immune(ACIU.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 37.8% and a total avera